Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol with Palonosetron/Dexamethasone for CINV Prevention
NCT00553059Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2008
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dronabinol in chemotherapy-induced nausea and vomiting (CINV), sponsored by University of Texas MD Anderson Cancer Center. Started May 2008; status: completed.
02
Drugs
dronabinol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00553059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553059.